A PHASE 4, 52-WEEK (PRIMARY ANALYSIS AT 24-WEEKS), RANDOMIZED, STRATIFIED, OPEN-LABEL, ACTIVE-CONTROLLED, PARALLEL-GROUP, EFFECTIVENESS STUDY, COMPARING FF/UMEC/VI WITH NON-ELLIPTA USUAL CARE (ICS/LABA) IN ADULT PARTICIPANTS WITH UNCONTROLLED ASTHMA
A PHASE 4, 52-WEEK (PRIMARY ANALYSIS AT 24-WEEKS), RANDOMIZED, STRATIFIED, OPEN-LABEL, ACTIVE-CONTROLLED, PARALLEL-GROUP, EFFECTIVENESS STUDY, COMPARING FF/UMEC/VI WITH NON-ELLIPTA USUAL CARE (ICS/LABA) IN ADULT PARTICIPANTS WITH UNCONTROLLED ASTHMA
Hi, this is a comment.
To get started with moderating, editing, and deleting comments, please visit the Comments screen in the dashboard.
Commenter avatars come from Gravatar.